Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | PIM1 | P11309 | 13/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16067241 | 1.00 | CYP2A6 (0.37) | CYP2A6PIM1CYP11B1PIM3PIM2 | |
| SCHEMBL16066189 | 0.96 | CYP11B1 (0.40) | CYP2A6PIM1CYP11B1PIM3PIM2 | |
| SCHEMBL16066986 | 0.95 | CYP11B1 (0.40) | CYP2A6PIM1CYP11B1PIM3PIM2 | |
| SCHEMBL17033524 | 0.92 | CYP2A6 (0.39) | CYP2A6PIM1CYP11B1PIM3PIM2 | |
| SCHEMBL16067222 | 0.89 | MKNK1 (0.35) | MAPTCYP2C9 | |
| SCHEMBL16066387 | 0.89 | MKNK1 (0.35) | MAPTCYP2C9 | |
| SCHEMBL16067219 | 0.89 | MEN1 (0.35) | — | |
| SCHEMBL16066464 | 0.89 | MEN1 (0.35) | — | |
| SCHEMBL17033596 | 0.88 | CYP2A6 (0.38) | CYP2A6PIM1CYP11B1PIM3PIM2 | |
| SCHEMBL16066229 | 0.87 | CYP2A6 (0.36) | CYP2A6PIM1CYP11B1PIM3PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014142488-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | 주식회사 두산 (KR) | 2014-09-18 | — | — | WO | disclosed |